From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Celadon CEO James Short now on very thin ice indeed as more bills go unpaid, but has he taken out any cash?

By Tom Winnifrith, the Sheriff of AIM | Wednesday 30 April 2025


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Celadon Pharmaceuticals (CEL) told us on March 31 that it had sufficient cash to last “into April” thanks to the support of creditors. In plain English it could last as long as various folks did not insist on being paid. Today it says that, with the same caveat, it can now last “into May.” CEO James Short is a proven chancer.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

TERN

My Tern for a victory lap

Thursday »

HAYD

Haydale – US disaster……Oh Dear!

Wednesday »

Gold

As Gold Battles $3,300, What For The Miners?

 

BOOM

Evil’s Rule: Audioboom

 

URU…Who R U Kidding?

Time left: 00:11:54